About Us
Enlyte News
There’s always something going on at Enlyte. Stay up to date with the latest developments.
Risk & Insurance: Why Employers Looking to Effectively Implement Telemedicine into Their Workers' Comp Program Could Take a Page Out of Starbucks' Book
Telemedicine is growing in popularity for workers' compensation programs. See how Starbucks successfully integrated telemedicine into its program to benefit its workforce.
Bamlanivimab Granted Emergency Use Authorization For Early COVID-19 Treatment
Bamlanivimab is an investigational monoclonal antibody treatment that has shown promise in treating mild-to-moderate COVID-19 infections.
Risk & Insurance: How Case Managers Can Assist Employees Who Are Delaying Care Due to COVID-Related Anxieties
Injured workers may try to delay treatment over fears that they will contract COVID-19. Nurse case managers can help keep them on track.
In a Hazy Election, Marijuana Is a Clear Winner
Voters in several states approved ballot measures to expand legalization of marijuana.
Evzio Naloxone Auto-Injectors Discontinued
Learn how this could affect the workers' compensation and auto casualty industries.
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an ever-changing list of experimental and unproven treatments.
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
Learn about how the approval may affect the workers' compensation industry.
See the P&C Industry From Our 360-Degree Vantage Point
In an ever-changing landscape, trusted knowledge is like gold. We’re the insiders you can count on to break down the opportunities and challenges facing the industry today, with the expertise to share actionable insights.
